Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Nuofeng Pharmaceutical (Chengdu)

Request full access

Global pharmaceutical group focusing on complex formulations

ChinaFounded 2018

About Nuofeng Pharmaceutical (Chengdu)

Zennova Pharmaceutical Group is a Cayman-registered international pharmaceutical company established in 2018 by founder, Chairman, and CEO Dahai Guo. The company operates with a strategic focus on 'China manufacturing, global R&D, and global market'. It concentrates on four main therapeutic areas: ophthalmology, virology, cardiovascular diseases, and oncology, with ophthalmology and oncology being its core strategic fields.

Zennova has established a significant global presence with R&D and production facilities in Chengdu, China, and R&D bases in New York and New Jersey in the US. The state-of-the-art manufacturing facility in Chengdu Tianfu International Biotown is designed to meet cGMP standards for the US FDA, EU EMA, and China. The company possesses proprietary drug development technology platforms, including Liquipuls™ and BioCarrier®, developed over two decades. Its product pipeline includes over 60 FDA-approved drugs for various conditions.

The company's business model integrates R&D, manufacturing, and sales. It aims to establish three parallel revenue streams: US R&D and production for US sales, China R&D and production for international sales, and China R&D and production for domestic sales. Zennova engages in strategic partnerships to expand its market reach. In June 2024, it partnered with Quagen Pharmaceuticals for contract manufacturing and international sales rights. A similar agreement was signed with AiPing Pharmaceuticals in March 2024 for international sales cooperation and supply chain integration. In July 2023, Zennova completed a Series B financing round of nearly 100 million yuan, led by Hengbao Holding, to be used for commercial production, market preparation, and new product development.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
14.3/100
Business model
Manufacturing
Links
Website

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Jul 2023 $14M $55M Guilin Hengbao Health Protection ↗
SERIES AEquity / VC Aug 2021 $0 — Dyee Capital ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Nuofeng Pharmaceutical (Chengdu) website traffic

Latest recorded traffic for Nuofeng Pharmaceutical (Chengdu) is 650 monthly website visits, up 242.1% over the last three months.

Latest monthly visits650 3-month web change+242.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Nuofeng Pharmaceutical (Chengdu) in its local ecosystem

Live from Dealroom

The Nuofeng Pharmaceutical (Chengdu) office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Dyee Capital
  • Guilin Hengbao Health Protection
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Nuofeng Pharmaceutical (Chengdu) on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nuofeng Pharmaceutical (Chengdu)’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.